Order Article Reprints

Thuluva S, Gunneri S, Ningaiah S, Yerroju V, Mogulla RR, Thammireddy K, Dhar C, Desai S, Paliwal P, Loka C, et al. Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14^®) Administered at 6–10–14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial. Vaccines. 2026; 14(6):464. https://doi.org/10.3390/vaccines14060464

Thuluva, Subhash, Subbareddy Gunneri, Siddalingaiah Ningaiah, Vijay Yerroju, Rammohan Reddy Mogulla, Kamal Thammireddy, Chirag Dhar, Shivani Desai, Piyush Paliwal, Chandrudu Loka, and et al. 2026. "Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14^®) Administered at 6–10–14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial" Vaccines 14, no. 6: 464. https://doi.org/10.3390/vaccines14060464

Thuluva, S., Gunneri, S., Ningaiah, S., Yerroju, V., Mogulla, R. R., Thammireddy, K., Dhar, C., Desai, S., Paliwal, P., Loka, C., Balne, N., Kommanapalli, S., Joshi, C., Agarwal, K. S., Charde, G. P., Narang, M., Narayan, J. P., Chakravarthy, B. S., Mahantshetti, N. S., ... Thakkar, P. A. (2026). Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14^®) Administered at 6–10–14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial. Vaccines, 14(6), 464. https://doi.org/10.3390/vaccines14060464